GlaxoSmithKline | GSK - Attività Correnti

Prezzo Delle Azioni
1,904.00
Cambio Giornaliero
-24.50 -1.27%
Mensile
-11.19%
Annuale
31.45%
Q2 Previsione
1,986.06




Attività Correnti Cambiamento Data
AbbVie USD 29.06B 523M 2025-12
Alcon AG USD 6.45B 116M 2025-12
Almirall EUR 713.98M 69K 2025-12
Amgen USD 29.06B 1.17B 2025-12
argenx SE USD 5.83B 946.64M 2025-06
AstraZeneca USD 29.61B 890M 2026-03
Bayer EUR 32.91B 30M 2025-12
Biogen USD 9.19B 216.3M 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Eli Lilly USD 54.84B 794M 2026-03
Fresenius EUR 12.06B 1.18B 2025-09
Fresenius Medical Care EUR 7.9B 74M 2025-12
Galapagos EUR 3.08B 82.56M 2025-12
Genmab DKK 2.88B 1.59B 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.76B 251M 2026-03
Glaxosmithkline GBP 23.59B 390.44M 2025-12
GRIFOLS EUR 5.07B 274.77M 2025-12
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Lonza CHF 8B 3.41B 2025-12
Merck EUR 13.23B 354M 2025-12
Merck USD 43.52B 4.04B 2025-12
Novartis USD 30.46B 2.26B 2025-12
Novo Nordisk DKK 172.45B 9.43B 2025-12
Orion EUR 1.41B 66.8M 2026-03
Pfizer USD 46.92B 3.22B 2025-09
Philips EUR 9.93B 654M 2025-12
Recordati EUR 1.71B 144.32M 2025-09
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.16B 789M 2026-03
Smith & Nephew USD 4.63B 169M 2025-12
UCB EUR 6.05B 733M 2025-12